Verastem Inc. has expanded its development reach to Japan with the beginning of an early-stage trial there of its lead candidate to treat mesothelioma.
Verastem Inc. has expanded its development reach to Japan with the beginning of an early-stage trial there of its lead candidate to treat mesothelioma.